Skip to content

Maestro 4000™ Controller M0044000H0Recalls & reported problems

Boston Scientific Corporation · RF Cardiac Ablation Controller · Class 3

All models of Maestro 4000 Controller (3)

Data updated Oct 16, 2026 from official FDA records · Editorial policy

Adverse event reports
3
Deaths reported
0
Injuries reported
0
Recalls naming it
0

Summary

The FDA's MAUDE database contains 3 adverse event reports that list this exact device (DI 08714729861935), received between Oct 17, 2019 and Oct 17, 2019 — classified as 3 malfunctions.

The most frequently reported specific device problem is “Device Remains Activated” (3 reports).

Reports come from manufacturers, hospitals and patients and are not verified by the FDA. A report does not prove the device caused the event, and counts can't be used to compare devices or estimate failure rates. What reports can and can't tell you · How this data works · Data updated Oct 16, 2026.

Most reported problems

Device problems

  • Device Remains Activated3

Patient problems

  • No Patient Involvement2
  • No Consequences Or Impact To Patient1

Recent adverse event reports

The 3 most recent of 3 reports, in the reporter's own words as published by the FDA.

  • MalfunctionOct 17, 2019Device Remains Activated; Device Remains Activated

    IT WAS REPORTED THAT THERE WAS A FAILURE TO HALT RADIOFREQUENCY (RF) ABLATION DELIVERY. DURING AN ABLATION PROCEDURE, WHILE ABLATING WITH THE FOOT PEDAL, ENERGIZATION CONTINUED EVEN WHEN THE FOOT PEDAL WAS REMOVED. ENERGIZATION WAS STOPPED VIA AN OFF SWITCH ON THE MAIN UNIT. THERE WERE NO REPORTED PATIENT ISSUES AND THE PATIENT OUTCOME WAS "GOOD."

    Patient problems: No Patient Involvement

    MAUDE report 9203586 ↗
  • MalfunctionOct 17, 2019Device Remains Activated; Device Remains Activated

    IT WAS REPORTED THAT THERE WAS A FAILURE TO HALT RADIOFREQUENCY (RF) ABLATION DELIVERY. DURING AN ABLATION PROCEDURE, WHILE ABLATING WITH THE FOOT PEDAL, ENERGIZATION CONTINUED EVEN WHEN THE FOOT PEDAL WAS REMOVED. ENERGIZATION WAS STOPPED VIA AN OFF SWITCH ON THE MAIN UNIT. THERE WERE NO REPORTED PATIENT ISSUES AND THE PATIENT OUTCOME WAS "GOOD."

    Patient problems: No Consequences Or Impact To Patient

    MAUDE report 9203561 ↗
  • MalfunctionOct 17, 2019Device Remains Activated; Device Remains Activated

    IT WAS REPORTED THAT THERE WAS A FAILURE TO HALT RADIOFREQUENCY (RF) ABLATION DELIVERY. DURING AN ABLATION PROCEDURE, WHILE ABLATING WITH THE FOOT PEDAL, ENERGIZATION CONTINUED EVEN WHEN THE FOOT PEDAL WAS REMOVED. ENERGIZATION WAS STOPPED VIA AN OFF SWITCH ON THE MAIN UNIT. THERE WERE NO REPORTED PATIENT ISSUES AND THE PATIENT OUTCOME WAS "GOOD."

    Patient problems: No Patient Involvement

    MAUDE report 9203558 ↗

Other Cardiac ablation percutaneous catheter devices

All Cardiac ablation percutaneous catheter devices →

Sources and updates

How reports and recalls are matched · Editorial policy · Report an error on this page